Summary
Signal counts
Assets tracked: 2
Watchlist assets: 2
Registry stop assets: 2
Sponsor overview
Columbia University
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT04109742 | https://clinicaltrials.gov/study/NCT01855607
Assets
Linked programs
- phosphatidylcholine-curcumin complex supplement: Registry Stop Signal (4/5)
- topical menthol: Registry Stop Signal (3/5)